JANE STREET GROUP, LLC - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 178 filers reported holding IMPAX LABORATORIES INC in Q4 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q4 2017$1,004,000
+239.2%
60,306
+618.3%
0.00%
+50.0%
Q3 2015$296,000
+6.1%
8,396
+38.1%
0.00%0.0%
Q2 2015$279,000
-45.4%
6,079
-44.2%
0.00%
-50.0%
Q1 2015$511,000
+67.0%
10,900
+12.7%
0.00%
+100.0%
Q4 2014$306,000
+5.2%
9,669
-21.2%
0.00%
-33.3%
Q3 2014$291,000
-60.8%
12,277
-56.4%
0.00%
-62.5%
Q1 2014$743,00028,1390.01%
Other shareholders
IMPAX LABORATORIES INC shareholders Q4 2014
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 560,400$9,022,0003.93%
NORTH TIDE CAPITAL, LLC 1,000,000$16,100,0003.58%
Sivik Global Healthcare LLC 250,000$4,025,0001.47%
MAVERICK CAPITAL LTD 7,159,336$115,265,0001.44%
SECTOR GAMMA AS 589,311$9,488,0001.38%
BRIDGER MANAGEMENT, LLC 1,341,143$21,592,0001.23%
Eos Focused Equity Management, L.P. 48,714$784,0000.89%
Bridge City Capital, LLC 47,194$760,0000.64%
Fosun International Ltd 300,000$4,830,0000.60%
Century Capital Management, LLC 203,138$3,271,0000.56%
View complete list of IMPAX LABORATORIES INC shareholders